Interestingly, TGF-β can play a dual role in HCC; in the earlier phases it enhances the anti-tumorigenic activity, but during the progression of the carcinoma, it switches to become a pro-tumorigenic factor [55]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.